France Biopharmaceutical Cro Market Size & Outlook

The biopharmaceutical cro market in France is expected to reach a projected revenue of US$ 1,515.4 million by 2033. A compound annual growth rate of 8.4% is expected of France biopharmaceutical cro market from 2025 to 2033.
Revenue, 2024 (US$M)
$743.8
Forecast, 2033 (US$M)
$1,515.4
CAGR, 2025 - 2033
8.4%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France biopharmaceutical cro market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France biopharmaceutical cro market highlights

  • The France biopharmaceutical cro market generated a revenue of USD 743.8 million in 2024 and is expected to reach USD 1,515.4 million by 2033.
  • The France market is expected to grow at a CAGR of 8.4% from 2025 to 2033.
  • In terms of segment, clinical was the largest revenue generating type in 2024.
  • Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.


Biopharmaceutical cro market data book summary

Market revenue in 2024USD 743.8 million
Market revenue in 2033USD 1,515.4 million
Growth rate8.4% (CAGR from 2025 to 2033)
Largest segmentClinical
Fastest growing segmentPre-Clinical
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Pre-Clinical, Clinical


Other key industry trends

  • In terms of revenue, France accounted for 2.6% of the global biopharmaceutical cro market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany biopharmaceutical cro market is projected to lead the regional market in terms of revenue in 2033.
  • Germany is the fastest growing regional market in Europe and is projected to reach USD 2,441.2 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharmaceutical CRO Market Companies

Name Profile # Employees HQ Website
Medpace View profile - - -
Clinipace View profile - - -
LabCorp View profile - - -
WuXi AppTec View profile - - -
Fortrea Holdings Inc View profile 16000 8 Moore Drive, Durham, NC, United States, 27709 https://www.fortrea.com
IQVIA View profile 10001+ Danbury, Connecticut, United States, North America https://www.iqvia.com
Worldwide Clinical Trials View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.worldwide.com
Syneos Health View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.syneoshealth.com/
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com

France biopharmaceutical cro market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical cro market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 80.94% in 2024. Horizon Databook has segmented the France biopharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to France biopharmaceutical cro market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France biopharmaceutical cro market databook

  • Our clientele includes a mix of biopharmaceutical cro market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France biopharmaceutical cro market , including forecasts for subscribers. This country databook contains high-level insights into France biopharmaceutical cro market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France biopharmaceutical cro market size, by type, 2021-2033 (US$M)

France Biopharmaceutical CRO Market Outlook Share, 2024 & 2033 (US$M)

France biopharmaceutical cro market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online